Search research articles
Contact Us
Filters
Showing results (51-60 of 124) with videos related to
Page
of 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250
Daniel A Pryma, Joseph A O'Donoghue, John L Humm, et al.
Endocrine-Related Cancer
|
December 6, 2022
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma
Camilo Jimenez, Bennett B Chin, Richard B Noto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2025
Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace
Victor V Onecha, Daniel Suarez-García, Jesús J Bosque, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
The Lancet Oncology Commission: Radiotherapy & Theranostic Services in LMICs: Minding & Mending the Gaps
Jaleelat I Momodu, Claudia Carvajal, Daniel A Pryma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 29, 2020
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document
John M Buatti, Daniel A Pryma, Ana P Kiess, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy
Samuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Urology
|
March 5, 2013
A review of contemporary data on surgically resected renal masses--benign or malignant?
Anthony T Corcoran, Paul Russo, William T Lowrance, et al.
Plos One
|
February 14, 2020
The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes
Marie A Guerraty, H Shanker Rao, Venkatesh Y Anjan, et al.
Transplantation
|
June 22, 2022
Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant
Nicholas R Perkons, David C Metz, Evan S Siegelman, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 124) with videos related to
Sort By:
Page
of 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 23, 2011
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250
Daniel A Pryma, Joseph A O'Donoghue, John L Humm, et al.
Endocrine-Related Cancer
|
December 6, 2022
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma
Camilo Jimenez, Bennett B Chin, Richard B Noto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 23, 2025
Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace
Victor V Onecha, Daniel Suarez-García, Jesús J Bosque, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
The Lancet Oncology Commission: Radiotherapy & Theranostic Services in LMICs: Minding & Mending the Gaps
Jaleelat I Momodu, Claudia Carvajal, Daniel A Pryma, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 29, 2020
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document
John M Buatti, Daniel A Pryma, Ana P Kiess, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
January 25, 2017
PARP-1 Expression Quantified by [<sup>18</sup>F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy
Samuel Sander Effron, Mehran Makvandi, Lilie Lin, et al.
Urology
|
March 5, 2013
A review of contemporary data on surgically resected renal masses--benign or malignant?
Anthony T Corcoran, Paul Russo, William T Lowrance, et al.
Plos One
|
February 14, 2020
The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes
Marie A Guerraty, H Shanker Rao, Venkatesh Y Anjan, et al.
Transplantation
|
June 22, 2022
Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant
Nicholas R Perkons, David C Metz, Evan S Siegelman, et al.
Page
of 13